Healthtech Startups

HealthStream's Nursegrid Unlimited CE is a subscription service offering nurses unlimited access to continuing education courses that meet state-specific regulatory requirements for nursing practice compliance.

4 investors

Nutrisense provides personalized metabolic monitoring and health guidance through continuous glucose monitoring and data analysis. The platform helps individuals understand their body's metabolic response to food and lifestyle choices to build sustainable health habits.

4 investors

Nuvation Bio is a global oncology company developing and commercializing novel therapies for difficult-to-treat cancers, targeting indications where conventional treatments have failed. Its pipeline of therapeutic candidates addresses drug resistance and limited efficacy of current cancer therapies.

4 investors

NuvoAir provides virtual-first specialty care for patients with complex heart and lung (cardiopulmonary) conditions, offering proactive and continuous remote and in-person care. It serves patients and provider partners with services including virtual or in-person consultations and ongoing care team support.

4 investors

Octave is a mental health practice platform that connects licensed therapists with patients seeking in-network mental health care. The company handles insurance credentialing, billing, scheduling, and client matching to support therapists and expand access to effective mental health treatment.

4 investors

Ocular Therapeutix focuses on drug development and treatment for retinal diseases, with an emphasis on wet age-related macular degeneration and expanding into diabetic retinopathy conditions. The company aims to reduce therapeutic burden and improve patient outcomes in retinal care.

4 investors

Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance. It focuses on improving treatment outcomes for patients living with breast cancer.

4 investors

OM1 develops AI-powered analytics and data infrastructure for healthcare organizations to measure patient outcomes, predict health trajectories, and accelerate medical research using real-world clinical data. The platform serves healthcare systems, pharmaceutical companies, and research organizations seeking to close evidence gaps and improve clinical decision-making.

4 investors

OMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs. The company builds integrated development and commercialization capabilities while partnering to advance programs addressing large indications.

4 investors

Ome makes smart knobs that retrofit onto existing stoves to prevent kitchen fires through automatic shut-off, remote monitoring, and cooking timers. The product is designed for homeowners seeking fire safety without replacing their stove.

4 investors

OMNY Health operates a platform that connects patients, providers, and life sciences companies through data and insights to improve healthcare delivery and clinical outcomes.

4 investors

This company operated a cannabis software platform and marketplace for on-demand medical marijuana delivery in the United States. It verified a patient's eligibility under medical marijuana rules and connected adult consumers with licensed dispensaries and their product inventories via mobile devices. The business has since exited.

4 investors

Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma. The company is a Spanish biotech firm focused on oncology with support from European and Spanish government research funding programs.

4 investors

OncoHealth develops software and services to help health plans, employers, and oncologists manage cancer care and reduce treatment complexity. The platform combines oncology management tools with nursing, mental health, nutrition, and navigation services for patients and health systems.

4 investors

OneImaging offers an employer-sponsored medical imaging benefit that connects members to a national network of 4,800+ accredited radiology centers with upfront pricing and care navigation support. It integrates with members' existing insurance and negotiates lower rates for scans such as MRI, CT, ultrasound, mammograms, and X-rays to reduce out-of-pocket imaging costs.

4 investors

Onkos Surgical develops limb salvage and orthopedic reconstruction implants and systems for treating musculoskeletal cancer and complex orthopedic conditions. Its products focus on soft tissue attachment, avoiding aseptic loosening, and patient-specific reconstruction for surgeons and their patients, including pediatric bone tumor cases.

4 investors

OnShift provides workforce management and employee engagement software for long-term care, senior living, behavioral health, EMS, and home health providers. The platform enables these healthcare organizations to manage staffing based on census and acuity, monitor regulatory compliance, recruit and retain talent, and improve employee experience through earned wage access and rewards programs.

4 investors

Ophelia provides medication-assisted treatment for opioid addiction through a telemedicine platform, allowing patients to receive care without attending residential rehab. The service is designed for individuals struggling with opioid addiction who prefer privacy-respecting, home-based treatment options.

4 investors

OraPharma develops pharmaceutical products and tools for dental professionals to address oral health concerns, serving dental practices and patients. The company provides educational resources and partners with dental service organizations and academic institutions.

4 investors

Orasis is a pharmaceutical company developing drugs for the eye, operating in the ophthalmology and eyecare space. It is backed by healthcare-focused investors and announced a Series D financing in October 2024.

4 investors

Orbis Diagnostics is developing a point-of-care diagnostics platform that produces blood test results from a single fingerstick of blood. The product targets clinical blood testing in the medical diagnostics field.

4 investors

Orbit Discovery provides peptide discovery solutions for pharmaceutical and biotechnology companies, serving both large pharmaceutical firms and smaller biotech enterprises.

4 investors

Orchard Therapeutics develops ex vivo autologous hematopoietic stem cell (HSC) gene therapies for genetic and other severe diseases, including rare inherited conditions such as ADA-SCID and metachromatic leukodystrophy. The Nasdaq-listed biotech (ticker ORTX) has commercialized therapies including Strimvelis and Libmeldy in Europe.

4 investors

Orderly Health uses AI and machine learning to process provider roster updates and maintain a centralized provider directory, improving the accuracy and reliability of healthcare provider data. It serves healthcare providers, payers, and health technology companies for uses such as regulatory compliance, patient access, and market intelligence.

4 investors